Explain this page
Arphra AIPlain-English read on Intuitive Surgical, Inc.’s valuationInsider signal · 90d
Net sellers
Bought
$0
Sold
$499.8K
Txns
6
Over the trailing 90 days insiders are net sellers — $0 bought against $499.8K sold across 6 open-market Form-4 transactions. Much insider selling is scheduled (10b5-1); read the asymmetry, not any single print.
Open-market Form 4
· insider_tradesInsider transactions · last 365d
Net −$62.4M0 buys
| Insider | Role | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Brosius Mark | officer: EVP & Chief Mfg and Supply Cha | Sell | −23 | $9.8K | Jun 10, 2026 |
| Brosius Mark | officer: EVP & Chief Mfg and Supply Cha | Sell | −23 | $9.7K | Jun 09, 2026 |
| Brosius Mark | officer: EVP & Chief Mfg and Supply Cha | Sell | −23 | $9.7K | Jun 08, 2026 |
| LOEB GARY | officer: EVP & Chief Legal and Complian | Sell | −400 | $178.8K | May 11, 2026 |
| Ladd Amy L | director | Sell | −119 | $55.2K | Apr 29, 2026 |
| Ladd Amy L | director | Sell | −500 | $236.7K | Apr 28, 2026 |
| Curet Myriam | officer: EVP & Chief Medical Officer | Sell | −105 | $51.9K | Mar 10, 2026 |
| Brosius Mark | officer: SVP & Chief Mfg and Supply Cha | Sell | −645 | $312.8K | Mar 09, 2026 |
| Brosius Mark | officer: SVP & Chief Mfg and Supply Cha | Sell | −648 | $317.6K | Mar 06, 2026 |
| Brosius Mark | officer: SVP & Chief Mfg and Supply Cha | Sell | −648 | $320.9K | Mar 05, 2026 |
| Brosius Mark | officer: SVP & Chief Mfg and Supply Cha | Sell | −2,362 | $1.2M | Mar 04, 2026 |
| Curet Myriam | officer: EVP & Chief Medical Officer | Sell | −4,728 | $2.3M | Mar 03, 2026 |
| Brosius Mark | officer: SVP & Chief Mfg and Supply Cha | Sell | −648 | $316.3K | Mar 03, 2026 |
| Widman Fredrik | officer: VP Corporate Controller | Sell | −118 | $57.5K | Mar 03, 2026 |
Transaction mix · 365d
100%
Sells44 · $62.4M
Buys0 · $0
Top sellers · 365d
GUTHART GARY S · director−$44.8M
Brosius Mark · officer: EVP & Chief Mfg and Supply Cha−$5.6M
Curet Myriam · officer: EVP & Chief Medical Officer−$5.0M
Transactions
44
0 buys · 44 sells
Bought
$0
Open market
Sold
$62.45M
Open market
Net flow
−$62.45M
Buys − sells
Transactions
| Insider | Role | Action | Shares | Price | Value | Trade date | Filing |
|---|---|---|---|---|---|---|---|
| Brosius Mark | officer: EVP & Chief Mfg and Supply Cha | Sell | 23 | $424.14 | $9.76K | Jun 10, 2026 | Jun 10, 2026 |
| Brosius Mark | officer: EVP & Chief Mfg and Supply Cha | Sell | 23 | $421.13 | $9.69K | Jun 09, 2026 | Jun 10, 2026 |
| Brosius Mark | officer: EVP & Chief Mfg and Supply Cha | Sell | 23 | $420.12 | $9.66K | Jun 08, 2026 | Jun 10, 2026 |
| LOEB GARY | officer: EVP & Chief Legal and Complian | Sell | 400 | $446.95 | $178.78K | May 11, 2026 | May 11, 2026 |
| Ladd Amy L | director | Sell | 119 | $463.50 | $55.16K | Apr 29, 2026 | Apr 29, 2026 |
| Ladd Amy L | director | Sell | 500 | $473.46 | $236.73K | Apr 28, 2026 | Apr 29, 2026 |
| Curet Myriam | officer: EVP & Chief Medical Officer | Sell | 105 | $493.95 | $51.86K | Mar 10, 2026 | Mar 11, 2026 |
| Brosius Mark | officer: SVP & Chief Mfg and Supply Cha | Sell | 645 | $485.01 | $312.83K | Mar 09, 2026 | Mar 10, 2026 |
| Brosius Mark | officer: SVP & Chief Mfg and Supply Cha | Sell | 648 | $490.19 | $317.64K | Mar 06, 2026 | Mar 10, 2026 |
| Brosius Mark | officer: SVP & Chief Mfg and Supply Cha | Sell | 648 | $495.20 | $320.89K | Mar 05, 2026 | Mar 05, 2026 |
| Brosius Mark | officer: SVP & Chief Mfg and Supply Cha | Sell | 2,362 | $498.68 | $1.18M | Mar 04, 2026 | Mar 05, 2026 |
| Curet Myriam | officer: EVP & Chief Medical Officer | Sell | 4,728 | $487.18 | $2.3M | Mar 03, 2026 | Mar 03, 2026 |
| Brosius Mark | officer: SVP & Chief Mfg and Supply Cha | Sell | 648 | $488.10 | $316.29K | Mar 03, 2026 | Mar 05, 2026 |
| Widman Fredrik | officer: VP Corporate Controller | Sell | 118 | $487.18 | $57.49K | Mar 03, 2026 | Mar 03, 2026 |
| Curet Myriam | officer: EVP & Chief Medical Officer | Sell | 125 | $492.59 | $61.57K | Mar 02, 2026 | Mar 03, 2026 |
| Widman Fredrik | officer: VP Corporate Controller | Sell | 249 | $499.71 | $124.43K | Feb 27, 2026 | Mar 03, 2026 |
| WADORS PATRICIA L | officer: SVP Chief Human Resources Offi | Sell | 220 | $499.71 | $109.94K | Feb 27, 2026 | Feb 27, 2026 |
| Curet Myriam | officer: EVP & Chief Medical Officer | Sell | 2,345 | $499.71 | $1.17M | Feb 27, 2026 | Mar 02, 2026 |
| Curet Myriam | officer: EVP & Chief Medical Officer | Sell | 421 | $494.96 | $208.38K | Feb 11, 2026 | Feb 11, 2026 |
| Widman Fredrik | officer: VP Corporate Controller | Sell | 133 | $494.96 | $65.83K | Feb 11, 2026 | Feb 11, 2026 |
| Curet Myriam | officer: EVP & Chief Medical Officer | Sell | 105 | $494.65 | $51.94K | Feb 10, 2026 | Feb 11, 2026 |
| Curet Myriam | officer: EVP & Chief Medical Officer | Sell | 126 | $520.02 | $65.52K | Jan 29, 2026 | Jan 30, 2026 |
| GUTHART GARY S | director | Sell | 24,500 | $530.10 | $12.99M | Jan 27, 2026 | Jan 28, 2026 |
| Curet Myriam | officer: EVP & Chief Medical Officer | Sell | 125 | $532.61 | $66.58K | Jan 27, 2026 | Jan 28, 2026 |
| GUTHART GARY S | director | Sell | 1,400 | $531.53 | $744.14K | Jan 27, 2026 | Jan 28, 2026 |
| GUTHART GARY S | director | Sell | 1,400 | $531.52 | $744.13K | Jan 27, 2026 | Jan 28, 2026 |
| Brosius Mark | officer: See Remarks | Sell | 464 | $548.49 | $254.5K | Dec 15, 2025 | Dec 17, 2025 |
| Brosius Mark | officer: SVP & Chief Mfg and Supply Cha | Sell | 464 | $548.49 | $254.5K | Dec 15, 2025 | Dec 15, 2025 |
| Brosius Mark | officer: See Remarks | Sell | 312 | $547.36 | $170.78K | Dec 12, 2025 | Dec 17, 2025 |
| Brosius Mark | officer: SVP & Chief Mfg and Supply Cha | Sell | 4,500 | $547.36 | $2.46M | Dec 12, 2025 | Dec 15, 2025 |
| Curet Myriam | officer: EVP & Chief Medical Officer | Sell | 104 | $559.90 | $58.23K | Dec 10, 2025 | Dec 10, 2025 |
| GUTHART GARY S | director, officer: Executive Chair of the Board o | Sell | 22,806 | $570.89 | $13.02M | Dec 01, 2025 | Dec 02, 2025 |
| Curet Myriam | officer: EVP & Chief Medical Officer | Sell | 125 | $568.99 | $71.12K | Dec 01, 2025 | Dec 02, 2025 |
| BARRATT CRAIG H | director | Sell | 750 | $580.00 | $435K | Nov 12, 2025 | Nov 13, 2025 |
| Charlton Henry L | officer: EVP & Chief Commercial and Mkt | Sell | 4,731 | $580.00 | $2.74M | Nov 12, 2025 | Nov 13, 2025 |
| Charlton Henry L | officer: EVP & Chief Commercial and Mkt | Sell | 2,901 | $580.00 | $1.68M | Nov 12, 2025 | Nov 13, 2025 |
| Miller Brian Edward | officer: EVP & Chief Digital Officer | Sell | 2,202 | $575.00 | $1.27M | Nov 10, 2025 | Nov 12, 2025 |
| Curet Myriam | officer: EVP & Chief Medical Officer | Sell | 105 | $560.00 | $58.8K | Nov 10, 2025 | Nov 12, 2025 |
| Widman Fredrik | officer: VP Corporate Controller | Sell | 159 | $550.00 | $87.45K | Nov 05, 2025 | Nov 06, 2025 |
| Curet Myriam | officer: EVP & Chief Medical Officer | Sell | 125 | $543.00 | $67.88K | Oct 29, 2025 | Oct 29, 2025 |
| Curet Myriam | officer: EVP & Chief Medical Officer | Sell | 1,379 | $548.43 | $756.28K | Oct 28, 2025 | Oct 29, 2025 |
| GUTHART GARY S | director, officer: Executive Chair of the Board o | Sell | 28,800 | $547.56 | $15.77M | Oct 24, 2025 | Oct 27, 2025 |
| GUTHART GARY S | director, officer: Executive Chair of the Board o | Sell | 1,400 | $546.35 | $764.89K | Oct 24, 2025 | Oct 27, 2025 |
| GUTHART GARY S | director, officer: Executive Chair of the Board o | Sell | 1,400 | $546.18 | $764.66K | Oct 24, 2025 | Oct 27, 2025 |
By insider
- GUTHART GARY S−$44.79Mdirector0B · 7S
- Brosius Mark−$5.62Mofficer: EVP & Chief Mfg and Supply Cha0B · 12S
- Curet Myriam−$4.99Mofficer: EVP & Chief Medical Officer0B · 13S
- Charlton Henry L−$4.43Mofficer: EVP & Chief Commercial and Mkt0B · 2S
- Miller Brian Edward−$1.27Mofficer: EVP & Chief Digital Officer0B · 1S
- BARRATT CRAIG H−$435Kdirector0B · 1S
- Widman Fredrik−$335.19Kofficer: VP Corporate Controller0B · 4S
- Ladd Amy L−$291.89Kdirector0B · 2S
- LOEB GARY−$178.78Kofficer: EVP & Chief Legal and Complian0B · 1S
- WADORS PATRICIA L−$109.94Kofficer: SVP Chief Human Resources Offi0B · 1S
Beneficial ownership filings
Schedule 13D / 13G — investors holding more than 5% of ISRG-US.
DB · acquisition_ownership88
| Filed | Reporting person | Form | Type | Aggregate owned | % Class | Sole voting | Shared voting | Citizenship | |
|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | Vanguard Capital Management | — | IA | — | +7.49% | 0 | 0 | PENNSYLVANIA | SEC → |
| Mar 27, 2026 | The Vanguard Group | — | IA | — | 0.00% | 0 | 0 | PENNSYLVANIA | SEC → |
| Feb 14, 2022 | 52-0556948 | — | IA | — | +6.90% | 10.39M | 0 | Maryland | SEC → |
| Feb 10, 2022 | The Vanguard Group - 23-1945930 | — | IA | — | +7.86% | 0 | 604.94K | Pennsylvania For | SEC → |
| Feb 07, 2022 | (1) BlackRock, Inc. | — | HC | — | +7.40% | 23.27M | 0 | Delaware | SEC → |
| Feb 16, 2021 | 52-0556948 | — | IA | — | +8.10% | 3.74M | 0 | Maryland | SEC → |
| Feb 10, 2021 | The Vanguard Group - 23-1945930 | — | IA | — | +7.76% | 0 | 202.97K | Pennsylvania | SEC → |
| Jan 29, 2021 | (1) BlackRock, Inc. | — | HC | — | +7.60% | 7.97M | 0 | Delaware | SEC → |
| Feb 14, 2020 | 52-0556948 | — | IA | — | +8.90% | 4.01M | 0 | Maryland | SEC → |
| Feb 12, 2020 | The Vanguard Group - 23-1945930 | — | IA | — | +7.79% | 178.64K | 30.84K | Pennsylvania | SEC → |
| Feb 07, 2020 | FMR LLC | — | HC | — | +6.09% | 928.84K | 0 | Delaware | SEC → |
| Feb 07, 2020 | Abigail P. Johnson | — | IN | — | +6.09% | 0 | 0 | Delaware | SEC → |
| Feb 05, 2020 | (1) BlackRock, Inc. | — | HC | — | +7.40% | 7.43M | 0 | Delaware | SEC → |
| Feb 14, 2019 | 52-0556948 | — | IA | — | +9.00% | 3.73M | 0 | Maryland | SEC → |
| Feb 13, 2019 | Abigail P. Johnson | — | IN | — | +5.72% | 0 | 0 | Delaware | SEC → |
| Feb 13, 2019 | FMR LLC | — | HC | — | +5.72% | 1.09M | 0 | Delaware | SEC → |
| Feb 04, 2019 | (1) BlackRock, Inc. | — | HC | — | +7.30% | 7.32M | 0 | Delaware | SEC → |
| Feb 14, 2018 | 52-0556948 | — | IA | — | +10.30% | 4.03M | 0 | Maryland | SEC → |
| Feb 13, 2018 | Abigail P. Johnson | — | IN | — | +5.34% | 0 | 0 | Delaware | SEC → |
| Feb 13, 2018 | FMR LLC | — | HC | — | +5.34% | 742.51K | 0 | Delaware | SEC → |
| Feb 08, 2018 | (1) BlackRock, Inc. | — | HC | — | +7.10% | 6.96M | 0 | Delaware | SEC → |
| Feb 14, 2017 | FMR LLC | — | HC | — | +5.76% | 222.73K | 0 | Delaware | SEC → |
| Feb 14, 2017 | Abigail P. Johnson | — | IN | — | +5.76% | 0 | 0 | Delaware | SEC → |
| Feb 07, 2017 | 52-0556948 | — | IA | — | +13.40% | 1.66M | 0 | Maryland | SEC → |
| Apr 07, 2016 | Baillie Gifford & Co (Scottish partnership) | — | IA | — | +11.00% | 0 | 0 | SCOTLAND UK | SEC → |
| Feb 11, 2016 | Morgan Stanley | — | HC, CO | — | +3.60% | 1.33M | 0 | The state of organization is Delaware. | SEC → |
| Feb 11, 2016 | Morgan Stanley Investment Management Inc. | — | IA, CO | — | +3.60% | 1.33M | 0 | The state of organization is Delaware. | SEC → |
| Feb 10, 2016 | (1) BlackRock, Inc. | — | HC | — | +5.80% | 1.83M | 0 | Delaware | SEC → |
| Feb 03, 2016 | Baillie Gifford & Co (Scottish partnership) | — | IA | — | +11.00% | 0 | 0 | SCOTLAND UK | SEC → |
| Feb 12, 2015 | Morgan Stanley Investment Management Inc. | — | IA, CO | — | +5.60% | 2.01M | 0 | The state of organization is Delaware. | SEC → |
Showing 30 of 88 filings. All disclosures →
Top 10 holders · 8 quarters
13F position evolutionNo 13F history in
institutional_holders for ISRG-US.